Levosimendan in lung transplant recipients on VA‑ECMO

Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and remains debatable. This paper presents a clinic...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: S. V. Zhuravel, V. E. Aleksandrova, I. I. Utkina, N. K. Kuznetsova, E. A. Tarabrin
Materialtyp: Artikel
Språk:Russian
Publicerad: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-04-01
Serie:Вестник трансплантологии и искусственных органов
Ämnen:
Länkar:https://journal.transpl.ru/vtio/article/view/1152